Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
Grassley Seeks Answers from EpiPen Competitor
In early March 2017, Senator Chuck Grassley sent a letter to the manufacturer of Auvi-Q (an epinephrine injector similar to…
President Trump Meets with Democrats on Drug Prices
President Donald Trump recently met with several Democratic lawmakers regarding rising drug prices, including Representative…
JAMA Harps on PAOs
JAMA Internal Medicine recently published an article, “Patient Advocacy Organizations, Industry Funding, and Conflicts of…
2016-2025 Projections of National Health Expenditures Data Released
National health expenditure is expected to grow an average of 5.6% annually from 2016 through 2025, according to a report…
Op-Ed in The Hill on Allowing Medicare to Directly Negotiate Drug Prices
Dr.Rafael Fonseca, a Chair of the Department of Medicine at the Mayo Clinic in Arizona and Distinguished Mayo Investigator,…
CMS Releases Report on Drug Rebates
The Centers for Medicare and Medicaid Services (CMS) has released a new report highlighting the growth in rebates from drug…
Johnson & Johnson Announces Plans to Disclose Average Price Increases
As America continues to discuss the increase in the cost of prescription drugs, Johnson & Johnson (J&J) has announced that…
New York Governor Unveils Plan to “Curb” Drug Pricing
Mere days before President Donald Trump was sworn into office, when any national action could (or would) be taken on drug pricing,…
U.S. Senators Collins and McCaskill Release Drug Pricing Investigation…
United States Senators Susan Collins (R-ME) and Claire McCaskill (D-MO), the Chairwoman and Ranking Member of the Senate Aging…
Democrat Senators Send Letter to Trump On Drug Pricing
United States Senators Sherrod Brown (D-OH) and Al Franken (D-MN) led the charge to send a letter to President-Elect Donald Trump,…